Literature DB >> 16256175

The effect of vitamin A on CCl4-induced hepatic injuries in rats: a histochemical, immunohistochemical and ultrastructural study.

Semiha Noyan1, Ilkin Cavusoglu, F Zehra Minbay.   

Abstract

In this study, we aimed to investigate the effect of vitamin A on the transformation of the Ito cells to fibrogenic form and suppression of the development of fibrosis. Carbon tetrachloride intoxication was performed on rats for 2, 8, 12 or 20 weeks and 5x10(4) IU vitamin A (as retinol palmitate) was injected subcutaneously once every 4 weeks. Ito cells were detected by gold chloride impregnation, as well as desmin and alpha-smooth muscle actin (alpha-SMA) immunohistochemistry. Additionally, all groups were examined ultrastructurally. The number of Ito cells that were labelled positively with gold impregnation decreased in the fibrotic groups; however, alpha-SMA and desmin immunopositive Ito cells increased. The samples from animals that were treated with vitamin A showed an increase in labelling with gold impregnation but a decrease in alpha-SMA immunopositivity. The data showed that vitamin A can prevent hepatic injury, by suppressing the transformation of Ito cells to fibrogenic form. We conclude that vitamin A has potential for the treatment of hepatic fibrotic diseases. Alpha-SMA immunohistochemistry was found to be more informative than desmin immunohistochemistry for monitoring liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16256175     DOI: 10.1016/j.acthis.2005.09.001

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  8 in total

1.  Therapeutic effects of vitamin A on experimental cholestatic rats with hepatic fibrosis.

Authors:  Ken-ichi Murakami; Tatsuru Kaji; Ryuichi Shimono; Yoshihiro Hayashida; Hiroshi Matsufuji; Shinichiro Tsuyama; Rie Maezono; Ken-ichiro Kosai; Hideo Takamatsu
Journal:  Pediatr Surg Int       Date:  2011-02-03       Impact factor: 1.827

2.  Green Synthesis of Silymarin-Chitosan Nanoparticles as a New Nano Formulation with Enhanced Anti-Fibrotic Effects against Liver Fibrosis.

Authors:  Abdullah Saad Abdullah; Ibrahim El Tantawy El Sayed; Abdel Moneim A El-Torgoman; Abul Kalam; S Wageh; Maher A Kamel
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

3.  Immunohistochemical detection of p53 protein in basal cell skin cancer after microwave-assisted antigen retrieval.

Authors:  E Evke; F Z Minbay; S G Temel; Z Kahveci
Journal:  J Mol Histol       Date:  2008-12-19       Impact factor: 2.611

Review 4.  Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings.

Authors:  Concetta Panebianco; Jude A Oben; Manlio Vinciguerra; Valerio Pazienza
Journal:  Clin Exp Med       Date:  2016-09-21       Impact factor: 3.984

5.  Cellular and molecular effects of silymarin on the transdifferentiation processes of LX-2 cells and its connection with lipid metabolism.

Authors:  Caio Mateus Silva; Gustavo Duarte Ferrari; Luciane Carla Alberici; Osmar Malaspina; Karen C M Moraes
Journal:  Mol Cell Biochem       Date:  2020-03-17       Impact factor: 3.396

6.  In vitro inhibition of hepatic stellate cell activation by the autophagy-related lipid droplet protein ATG2A.

Authors:  Yun Hong; Sirui Li; Jifeng Wang; Youming Li
Journal:  Sci Rep       Date:  2018-06-18       Impact factor: 4.379

7.  Hepatoprotective effects of hoveniae semen cum fructus extracts in ethanol intoxicated mice.

Authors:  Ilje Cho; Joowan Kim; Jaijun Jung; Soohyun Sung; Jongkyu Kim; Namju Lee; Saekwang Ku
Journal:  J Exerc Nutrition Biochem       Date:  2016-03-31

8.  Preparation and Characterization of Silymarin-Conjugated Gold Nanoparticles with Enhanced Anti-Fibrotic Therapeutic Effects against Hepatic Fibrosis in Rats: Role of MicroRNAs as Molecular Targets.

Authors:  Abdullah Saad Abdullah; Ibrahim El Tantawy El Sayed; Abdel Moneim A El-Torgoman; Noweir Ahmad Alghamdi; Sami Ullah; S Wageh; Maher A Kamel
Journal:  Biomedicines       Date:  2021-11-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.